Search

everythinglearnresearchcommunity

for

Search:↓

Ultraviolet techniques help identify Grover’s Disease, which may be underdiagnosed in young people and females.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Infrared light helped heal acid burns and improved neck movement.

Infrared thermography, especially with dermoscopy, improves accuracy in diagnosing active hair loss due to inflammation.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

The rash worsened due to a fungal infection masked by corticosteroids.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Tamsulosin increases the risk of floppy iris syndrome during cataract surgery.

Baricitinib helps with early hair regrowth in people with alopecia areata.

Nearly half of children with primary immunodeficiency disorders showed skin problems, often as the first sign of their condition.

Baricitinib effectively treated hair loss and inflammation in a patient with alopecia areata and lichen planopilaris.

Recurrent NICF is a rare skin condition with unclear causes, involving follicle inflammation and crystal deposits.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Baricitinib significantly regrows hair in severe alopecia areata patients.

Cyclosporine cleared a woman's resistant skin condition quickly and kept it away for over a year.

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

A fungal infection was successfully treated with oral and topical antifungals after being misdiagnosed and worsened by corticosteroids.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.